Search Keyword:


Search option:


IID00982
UniprotQ15746
ProteinMyosin light chain kinase, smooth muscle
GeneMYLK
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1914
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 405-507 Homo trimer :
 Evidence X-RAY 6c6m A Reference
       Region 6c6m A 405-412 disorder
       Region 6c6m A 413-507 order
 Evidence X-RAY 6c6m B Reference
       Region 6c6m B 405-412 disorder
       Region 6c6m B 413-506 order
       Region 6c6m B 507-507 disorder
 Evidence X-RAY 6c6m C Reference
       Region 6c6m C 405-412 disorder
       Region 6c6m C 413-507 order
Seq 510-601 Monomer :
 Evidence NMR 2yr3 A Reference
       Region 2yr3 A 510-601 order
Seq 1238-1338 Monomer :
 Evidence NMR 2cqv A Reference
       Region 2cqv A 1238-1338 order
       Region 2cqv A 1332-1338 high_rmsd
Seq 1742-1761 Hetero dimer : IID00706Complex
 Evidence X-RAY 5jqa B Reference
       Region 5jqa B 1742-1761 order
 Evidence X-RAY 5jth B Reference
       Region 5jth B 1742-1761 order
 Evidence NMR 2k0f B Reference
       Region 2k0f B 1742-1760 order
       Region 2k0f B 1760-1760 high_rmsd
Seqphosphorylation
    1779-1779 Phosphoserine
    1778-1778 Phosphothreonine
    1776-1776 Phosphoserine
    1773-1773 Phosphoserine
    1760-1760 Phosphoserine
    1772-1772 Phosphoserine
    1759-1759 Phosphoserine
    1635-1635 Phosphotyrosine; by ABL1
    1575-1575 Phosphotyrosine; by ABL1
    1449-1449 Phosphotyrosine; by ABL1
    1438-1438 Phosphoserine
    947-947 Phosphoserine
    846-846 Phosphotyrosine; by ABL1
    792-792 Phosphotyrosine; by ABL1
    611-611 Phosphotyrosine; by ABL1
    556-556 Phosphotyrosine; by ABL1
    471-471 Phosphotyrosine; by SRC
    464-464 Phosphotyrosine; by ABL1 and SRC
    365-365 Phosphoserine
    343-343 Phosphoserine
    305-305 Phosphoserine
    231-231 Phosphotyrosine; by ABL1
Seqacetylation
    2-2 N-acetylalanine
    2-2 N-acetylalanine
    608-608 N6-acetyllysine
 
Prediction
NeProc
Disorder 12-25,131-157,262-335,341-348,354-411,605-620,909-920,960-1032,1075-1095,1196-1230,1431-1443,1724-1729,1764-1797,1905-1914
Order 1-11,26-130,158-254,336-340,349-353,412-506,511-604,621-814,820-908,921-959,1033-1074,1096-1189,1231-1426,1444-1723,1730-1763,1798-1904
ProS 12-25,131-136,271-335,341-348,354-371,379-387,960-996,1003-1020,1025-1032,1075-1079,1221-1230,1431-1443,1724-1729,1764-1770,1778-1797
AlphaFold
Disorder 1-31,59-61,75-76,82-87,111-112,125-159,238-239,252-412,455-460,505-512,602-621,649-649,667-667,700-702,713-719,747-747,762-766,773-773,812-1095,1125-1125,1141-1142,1189-1234,1274-1275,1425-1450,1468-1468,1470-1476,1497-1499,1517-1521,1541-1545,1548-1556,1589-1589,1592-1602,1607-1607,1613-1624,1664-1665,1681-1682,1684-1684,1725-1725,1727-1729,1732-1808,1861-1861,1888-1889,1901-1914
Order 32-58,62-74,77-81,88-110,113-124,160-237,240-251,413-454,461-504,513-601,622-648,650-666,668-699,703-712,720-746,748-761,767-772,774-811,1096-1124,1126-1140,1143-1188,1235-1273,1276-1424,1451-1467,1469-1469,1477-1496,1500-1516,1522-1540,1546-1547,1557-1588,1590-1591,1603-1606,1608-1612,1625-1663,1666-1680,1683-1683,1685-1724,1726-1726,1730-1731,1809-1860,1862-1887,1890-1900
Pfam Hmmer
161->250 33-123 414->504
SEG 371-387 ,830-847 ,964-979 ,1223-1238 ,1345-1357 ,1426-1448 ,1903-1914
Function
Function in SwissProt
Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activity. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis.
Biological Process
Diagram with PDB data
MYLK/CALM1Calmodulin complexed with calmodulin-binding peptide from smooth muscle myosin light chain kinase